21st International Congress » Parkinson's Disease: Non-Motor Symptoms

Date: Monday, June 5, 2017

Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:45pm-3:15pm: Normal “heart” in Parkinson’s disease: Is this a distinct clinical phenotype?

J.E. Lee, J.-S. Kim, Y.-S. Oh, D.-W. Ryu, I.-U. Song, K.-S. Lee (Seoul, Republic of Korea)

1:45pm-3:15pm: “Home made” olfactory spice discrimination test for PD

D. Flisar, M. Trost, M. Brglez (Ljubljana, Slovenia)

1:45pm-3:15pm: A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)

1:45pm-3:15pm: A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease

A. Sauerbier, L. Klingelhoefer, R. Banerjee, S. Diaconu, R. Erro, T. Farombi, S. Gangadharan, A. Macerollo, L. Chahine, O. Jitkritsadakul, R. Biundo, M. Grilo, H. Dafsari, G. Pagano, F. Niccolini, N. Titova (London, United Kingdom)

1:45pm-3:15pm: A new aroma in the new world

H. Fajardo, A. Medina, P. Gomez, r. Medina (tegucigalpa, Honduras)

1:45pm-3:15pm: AAV-mediated human alpha synuclein overexpression in the locus coeruleus (LC) leads to a neuronal loss in the nucleus ambiguus of mouse.

B. Lee, M. Henrich, W.-H. Chiu, L. Matschke (Marburg, Germany)

1:45pm-3:15pm: Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, A. Numao, H. Fujita, Y. Watanabe, T. Matsubara, M. Miyamoto, K. Kaga, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)

1:45pm-3:15pm: An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson’s disease.

Y. Yamanishi, R. Ando, C. Yamasaki, S. Tada, N. Miyaue, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, M. Nomoto (Ehime, Japan)

1:45pm-3:15pm: An auditory biomarker for Parkinson’s Disease ?

K. De Keyser, A. Bockstael, D. Botteldooren, D. Talsma, M. De Letter, P. Santens (Ghent, Belgium)

1:45pm-3:15pm: Are patients with Parkinson’s disease who have either mild to moderate microsmia, severe microsmia or anosmia clinically different?

c. cox, A. Khattab, K. Amar (Bournemouth. Dorset, United Kingdom)

1:45pm-3:15pm: Assessment of Autonomic Dysfunction in Parkinson’s Disease

K. Karbozova, , (Bishkek, Kyrgyzstan)

1:45pm-3:15pm: Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin (Madrid, Spain)

1:45pm-3:15pm: Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease

T. Nakamura, M. Suzuki, M. Ueda, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

1:45pm-3:15pm: Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores

M. Leehey, S. Luo, S. Sharma, A.-M. Wills, J. Bainbridge, D. Simon, J. Schneider, Y. Zhang, A. Pérez, R. Dhall, C. Christine, C. Singer, F. Cambi (Aurora, CO, USA)

1:45pm-3:15pm: Association of pain and depression with Parkinson’s disease-osteoarthritis comorbidity.

A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

1:45pm-3:15pm: Association of pain in Parkinson’s disease with anxiety, depression and sleep quality: a cross-sectional study

A.Q. Rana, U. Saeed, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

1:45pm-3:15pm: Autonomic Dysfunction in Early Parkinson’s Disease: Cross-Sectional Study in Hoehn and Yahr Stage 1

I. Stankovic, I. Petrovic, T. Pekmezovic, T. Stojkovic, V. Markovic (Belgrade, Serbia)

1:45pm-3:15pm: Baseline risk factors of insomnia symptoms after five years of follow-up: a population-based cohort of incident Parkinson’s disease

A. Duarte Folle, B. Ritz, K. Paul (Los Angeles, CA, USA)

1:45pm-3:15pm: Burden of autonomic neuropathy in Parkinson’s disease patients treated with advanced therapies

A. Romagnolo, A. Merola, M. Rosso, C. Comi, C. Artusi, M. Rizzone, M. Zibetti, S. Maule, L. Lopiano, A. Espay (Turin, Italy)

1:45pm-3:15pm: Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)

1:45pm-3:15pm: Cause-Specific Hazard of Motor and Nonmotor Long Term Complications of Idiopathic Parkinson’s Disease in a Hospital-based Outpatient Clinic Incident Cohort of 1333 Patients

S. Prange, C. Laurencin, t. danaila, m.-b. delphine, S. Thobois (bron, France)

1:45pm-3:15pm: Central Aortic Pressure in Parkinson’s Disease and Levodopa Effect

M. BALAL, M. DEMIRKIRAN (Adana, Turkey)

1:45pm-3:15pm: Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

K. Fifel (Leiden, Netherlands)

1:45pm-3:15pm: Clean intermittent catheterization in Parkinson’s disease: a case report

M. Tosin, C. Mecone, W. Macedo, A.P. Seabra, A. Barbosa, R. Sakakibara (RIO DE JANEIRO, Brazil)

1:45pm-3:15pm: Clinical characteristics of Parkinson’s disease developed from essential tremor

D.-W. Ryu, J.-S. Kim, K.-S. Lee, J.-W. Park (Seoul, Republic of Korea)

1:45pm-3:15pm: Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort

R. Taddei, A. Sauerbier, M. Qamar, K. Ray Chaudhuri (London, United Kingdom)

1:45pm-3:15pm: Clinical Predictors of Dementia and Other Non-Motor Symptoms in Parkinson’s Disease

D. Lichter, S. Finnegan (Buffalo, NY, USA)

1:45pm-3:15pm: Cognitive Mechanisms of Visual Dysfunction in Non-Demented PD Patients (PD-ND)

T. Lin, H. Gibler, S. Rapcsak (Tucson, AZ, USA)

1:45pm-3:15pm: Correlation and impact of non-motor symptoms on intensity of motor symptoms in Parkinson’s Disease

M. Sanoeva, M. Gulova, N. Mansurova (bukhara, Uzbekistan)

1:45pm-3:15pm: Deep Brain Stimulation and Olfactory Function in Parkinson’s Disease

O. Saatci, B. Polat, N. Helvaci Yilmaz, T. Zirh (Istanbul, Turkey)

1:45pm-3:15pm: Diabetes Mellitus and Parkinson’s Disease

G. Pagano, S. Polychronis, H. Wilson, F. Niccolini, M. Politis (London, United Kingdom)

1:45pm-3:15pm: Diagnosis of Irritable Bowel Syndrome Increases Risk of Parkinson’s Disease in the Finnish Population

T. Mertsalmi, E. Pekkonen, F. Scheperjans (HUS, Finland)

1:45pm-3:15pm: Differential effects of ventral or dorsal predominant dopaminerjic denervation of striatum on development of dopamine dysregulation syndrome and punding in a rat model of parkinsonism

E. Özkan, G. Çakmaklı, B. Elibol, E. Topçuoğlu (Ankara, Turkey)

1:45pm-3:15pm: Do motor symptoms influence on malnutrition in Parkinson`s disease patients?

S. Tomic, V. Pekic, Z. Popijac, T. Pucic, M. Petek, T. Gilman Kuric (Osijek, Croatia)

1:45pm-3:15pm: Does gender influence the expression of non-motor symptoms in Parkinson’s disease?: An observational study

J. Herreros Rodríguez, A. Esquivel López, R. Gordo Mañas, Á. Sánchez Ferro (Madrid, Spain)

1:45pm-3:15pm: Dream content in Parkinson’s Disease

V. Malgrati, F. Mancini, L. Manfredi, M. Lacerenza, A. Maggiolini (Milan, Italy)

1:45pm-3:15pm: Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease

E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz (Ordu, Turkey)

1:45pm-3:15pm: Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

1:45pm-3:15pm: Emergence of Non-motor Fluctuations with Reference to Motor Fluctuations in Parkinson’s Disease

A. Kim, Y. Kim, A. Kim, C.W. Shin, B. Jeon, H. Kim (Seoul, Republic of Korea)

1:45pm-3:15pm: Evaluating Non-Motor Fluctuations in Parkinson’s Disease Using a Visual Analogue Scale

E. Brown, K. Dodenhoff, J. Ostrem, C. Racine (San Francisco, CA, USA)

1:45pm-3:15pm: Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations

O. Babkina, O. Levin, M. Poluektov (Moscow, Russian Federation)

1:45pm-3:15pm: Extreme Premature Ejaculation in Parkinson’s disease

G. Yahalom, G. Bronner, S. Israeli-Korn, S. Hassin-Baer (Ramat-Gan, Israel)

1:45pm-3:15pm: Female reproductive factors and clinical features of PD

H. Liu, R. Ou, Y. Hou, Q. Wei, W. Song, B. Cao, B. Zhao, H. Shang (Chengdu, China)

1:45pm-3:15pm: Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression

E. Dalle, D. William, M. Musa (Durban, South Africa)

1:45pm-3:15pm: Gastroesophageal dysmotility in advanced Parkinson’s Disease

F. Mancini, M. Lacerenza, L. Manfredi, A. Bestetti (Milan, Italy)

1:45pm-3:15pm: Gastrointestinal transit time in Parkinson’s disease -a novel 3D method

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

1:45pm-3:15pm: Gender differences in motor and non-motor features across the Parkinson’s disease spectrum

T. Dunne, G. Stebbins, C. Goetz, S. Luo, J. Goldman (Chicago, IL, USA)

1:45pm-3:15pm: Genetic susceptibility associated to impulse control disorders and compulsive behaviors in Parkinson’s disease from a Spanish population.

S. JESUS, C. TEJERA-PARRADO, C. CORTES, M. BONILLA-TORIBIO, I. BERNAL-BERNAL, M. LABRADOR, L. VARGAS-GONZÁLEZ, M. BERNAL, A. ADARMES, F. CARRILLO, M. CARBALLO, P. GÓMEZ-GARRE, P. MIR (SEVILLA, Spain)

1:45pm-3:15pm: Heart rate variability in Parkinson’s Disease and idiopathic REM sleep behavior disorder and relation with other non-motor symptoms

P. Bugalho, M. Mendonça, T. Lampreia, R. Miguel, R. Barbosa, M. Salavisa (Lisbon, Portugal)

1:45pm-3:15pm: High-Resolution Manometry (HRM) in Parkinson’s Disease (PD)

S. Brillman, C. Barlow, J. Cedarbaum, R. Gandhy, J. Langston, L. Rees, A. Su, G. Triadafilopoulos (Sunnyvale, CA, USA)

1:45pm-3:15pm: Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease

E. De Pablo-Fernandez, J. Holton, T. Warner (London, United Kingdom)

1:45pm-3:15pm: Impact of Duopa™ on Non-Motor Symptoms of Parkinson’s Patients with Deep Brain Stimulation

A. Wadhwa, R. Govindarajan, I. Asher (Columbia, MO, USA)

1:45pm-3:15pm: Improved sleep quality evaluated by Parkinson’s disease sleep scale after deep brain stimulation of globus pallidus internus

N. Nishida, H. Toda, H. Saiki, S. Matsumoto, K. Iwasaki (Osaka, Japan)

1:45pm-3:15pm: Impulse control disorder and associated clinical factors in drug-naïve Parkinson’s disease.

D. Gupta, M. Marano, S. Fahn (New York, NY, USA)

1:45pm-3:15pm: Impulse Control Disorders in Early Onset and Familial PD

R. Rees, N. Williams, Y. Ben-Shlomo, D. Grosset, H. Morris (London, United Kingdom)

1:45pm-3:15pm: Impulsive-compulsive behaviors in patients with Parkinson´s disease in Kannur, India

N. Svensson, S. Ovallath, R. Constantinescu (Göteborg, Sweden)

1:45pm-3:15pm: Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

K. Stepanchenko (Kharkiv, Ukraine)

1:45pm-3:15pm: Investigating the Association between Anxiety and Cognitive Impairment in Parkinson’s Disease: A Descriptive Study

A. Toft, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, D. Copland, N. Dissanayaka (Brisbane, Australia)

1:45pm-3:15pm: Investigation of Non-Motor Symptoms Impacting Care Dependency in Individuals with Parkinson’s Disease

M. Bryant, A. Tan, J.-G. Hou, E. Protas (Houston, TX, USA)

1:45pm-3:15pm: Is cognitive decline similar among Parkinson’s disease motor sub-types? A prospective study examining changes over time in gait, balance and cognition

T. Herman, L. Arie, S. Shema-Shiratzky, N. Giladi, J. Hausdorff (Tel Aviv, Israel)

1:45pm-3:15pm: Lifelong daily workload and postural abnormalities in patients with Parkinson’s disease

T. Maeda (Morioka, Japan)

1:45pm-3:15pm: Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann (Cologne, Germany)

1:45pm-3:15pm: Long-term levodopa therapy accelerates the circadian rhythm dysfunction in 6-OHDA rat model

D. Lv, Y. Wang, F. Wang, X. Zhang, X. Gu, Y. Yang (Suzhou, China)

1:45pm-3:15pm: Lower education level is associated with greater disability from pain in Parkinson’s disease patients

A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

1:45pm-3:15pm: Lower urinary tract symptoms in patients with Parkinson’s Disease: findings from a Tunisian cohort

A. Nasri, M. Ben Djebara, Y. Sidhom, K. Achour, I. Kacem, A. Gargouri, R. Gouider (Manouba, Tunisia)

1:45pm-3:15pm: Motor and non-motor symptoms in old-age onset Parkinson’s Disease patients

M. Mendonça, T. Lampreia, R. Miguel, A. Caetano, R. Barbosa, P. Bugalho (Lisboa, Portugal)

1:45pm-3:15pm: Motor complications and others of therapy but not non-motor symptoms burden predict short-term mortality in non-demented Parkinson´s disease patients

D. Santos García, E. Suárez Castro, I. Expósito Ruíz, C. Tuñas Gesto, M. Aneiros Díaz, M. López Fernández, T. de Deus, D. Núñez Arias, J. Ernández (Ferrol, Spain)

1:45pm-3:15pm: Motor performance measured with the UPDRS in PD patientswith varying degrees of smell loss

c. cox, A. Kahttab, K. Amar (Bournemouth. Dorset, United Kingdom)

1:45pm-3:15pm: Neuroanatomical correlates of depressive symptoms in newly diagnosed Parkinson’s disease patients

S.J. Kim (Busan, Republic of Korea)

1:45pm-3:15pm: Neuropsychiatric symptoms after bilateral stimulation in Parkinson’s disease: subthalamic nucleus versus globus pallidus internus.

F. Fonoff, E. Fonoff, R. Machado, R. Cury, M.G. dos Santos, E. Barbosa (São Paulo, Brazil)

1:45pm-3:15pm: Non-motor features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson’s disease in a PPMI cohort .

M. Stamelou, C. Koros, A. Simitsi, I. Beratis, X. Geronicola Trapali, D. Papadimitriou, N. Papagiannakis, A. Prentakis, D. Kontaxopoulou, S. Fragkiadaki, R. Antonelou, S. Papageorgiou, L. Stefanis (Athens, Greece)

1:45pm-3:15pm: Non-motor symptoms in a cross section of PD patients with varying degrees of smell loss

c. cox, A. Khattab, K. Amar (Bournemouth. Dorset, United Kingdom)

1:45pm-3:15pm: Non-motor symptoms in Parkinsons’s disease patients treated with levodopa-carbidopa intestinal gel infusion- the follow up study

A. Križnar, N. Zupančič Križnar, M. Kramberger, J. Bon, R. Rajnar, L. Ocepek, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

1:45pm-3:15pm: Non-motor symptoms in patients with Parkinson’s disease, essential tremor and both diseases – a group comparison

I. Wurster, A. Abaza, K. Brockmann, M. Rüdiger-Albers, S. Lerche, D. Berg (Tübingen, Germany)

1:45pm-3:15pm: Non-motor symptoms in the first neurology consultation in Cali – Colombia

J. Valderrama-Chaparro, J. Sanchez-Morante, Y. Ariza-Araujo, A. Enriquez-Marulanda, B. Munoz, J. Orozco (cali, Colombia)

1:45pm-3:15pm: NonMotor and Motor symptoms in Idiopathic Parkinson´s Disease and Secondary parkinsonism The “Parkinsons Well-Being MapTM” – a useful instrument in Clinical praxis.

Ö. Skogar, M. Nilsson, S. Morberg (Jönköping SWEDEN, Sweden)

1:45pm-3:15pm: Nonmotor disorders in Parkinsonism: Experience in Kyrgyz Republic

C. Shambetova (Bishkek, Kyrgyzstan)

1:45pm-3:15pm: Nonpharmacological therapies for sleep disturbances in Parkinson’s disease patients: A Systematic review

J. Lee, Y. Kim (Seoul, Republic of Korea)

1:45pm-3:15pm: Olfaction and gustation in patients with Parkinson’s Disease

A. Tautscher-Basnett, V. Tomantschger, M. Freimueller (Hermagor, Austria)

1:45pm-3:15pm: Olfactory deficits in the cognitive impaired de novo patients with Parkinson’s disease

J.S. Baik, H.I. Ma (Seoul, Republic of Korea)

1:45pm-3:15pm: Olfactory dysfunction in patient of Scans Without Evidence of Dopaminergic Deficit with parkinsonian bradykinesia

S.J. Kang, J.Y. Ahn, H.-T. Kim (Seoul, Republic of Korea)

1:45pm-3:15pm: Pain and Parkinson’s disease

H. Wilson, T. Yousaf, G. Pagano, M. Politis (London, United Kingdom)

1:45pm-3:15pm: Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation

K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer (Aarhus, Denmark)

1:45pm-3:15pm: Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?

M. Rosso, A. Merola, A. Romagnolo, C. Comi, A. Fasano, M. Zibetti, R. Lopez-Castellanos, D. Cocito, L. Lopiano, A. Espay (Cincinnati, OH, USA)

1:45pm-3:15pm: Parkinson’s Disease and Urogenital Dysfunction

N. Sözer, M. Yenice, H. Erdogan, E. Demir, I. Yiğitbaşı, V. Tuğcu, V. Yayla (Istanbul, Turkey)

1:45pm-3:15pm: Parkinson’s disease patients with cognitive impairment more sensitive to pain?

K. Abe, K. Fukushima, K. Ando, Y. Maeda, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)

1:45pm-3:15pm: Parkinson’s disease and progressive dysphagia – consider myasthenia gravis

P. Urban (Hamburg, Germany)

1:45pm-3:15pm: Parkinson’s Disease from the Patient Perspective

L. Mischley, G. Canada, R. Lau (Kenmore, WA, USA)

1:45pm-3:15pm: Parkinson’s disease phenotype across different ethnic groups: Comparison of non-motor symptoms in patients living in the United Kingdom and Mexico

A. Sauerbier, M. Rodriguez Violante, A. Cervantes Arriaga, A. Rizos, D. Trivedi, P. Martinez-Martin, M. Parry, M. Rosa-Grilo, R. Brown, K. Ray Chaudhuri (London, United Kingdom)

1:45pm-3:15pm: Phasic activity during non REM sleep

R. Miguel, I. Arnulf (Lisboa, Portugal)

1:45pm-3:15pm: Predicting the onset of freezing of gait: A longitudinal study

K. Ehgoetz Martens, E. Lukasik, M. Georgiades, M. Gilat, J. Hall, C. Walton, S. Lewis (Camperdown, Australia)

1:45pm-3:15pm: Prevalence of burning mouth syndrome in Parkinson disease

X.X. Yu, H. Fernandez (Cleveland, OH, USA)

1:45pm-3:15pm: Probiotic correction of intestinal dysbiosis in Parkinson’s disease

I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)

1:45pm-3:15pm: Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria

T. Farombi, A. Ogunniyi (Ibadan, Nigeria)

1:45pm-3:15pm: Real-world non-motor score changes in Parkinson’s disease patients with motor fluctuations: The J-FIRST study

H. Watanabe, H. Saiki, S.-W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, T. Maeda, Y. Shimo (Nagoya, Japan)

1:45pm-3:15pm: Relationship between neuropsychological functioning and subjective measures of sleep quality in Parkinson Disease

E. Montanaro, M. Zibetti, F. Dematteis, L. Lopiano (Torino, Italy)

1:45pm-3:15pm: Relationship between sleep profiles and clinical features in Parkinson’s disease

Y.-Y. Lin, R.-S. Chen, C.-S. Lu, Y.-Z. Huang, Y.-H. Weng, T.-H. Yeh, W.-Y. Lin, J. Hung (Taoyuan, Taiwan)

1:45pm-3:15pm: Riding the puzzle: deep brain stimulation and the non-motor symptoms in Parkinson’s disease

A.C. Campos, E. Talamoni Fonoff, C. Hamani, R. Lima Pagano (São Paulo, Brazil)

1:45pm-3:15pm: Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.

C. Cattaneo (Bresso (Milan), Italy)

1:45pm-3:15pm: Saliva changes and the oral health in Parkinson´s disease

J. Tiigimäe-Saar, T. Tamme, P. Taba (Tartu, Estonia)

1:45pm-3:15pm: Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration

N. Titova, S. Cankaya, F. Spinnato, E. Katunina, P. Martinez-Martin, M. Qamar, K.R. Chaudhuri (Moscow, Russian Federation)

1:45pm-3:15pm: Sexual Dysfunction in Women with Parkinson’s Disease

A. Hannoun, E. Adams, K. Smith, N. Cohen, A. Deb (Worcester, MA, USA)

1:45pm-3:15pm: Sleep quality in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel infusion

O. De Fabregues, A. Ferré, O. Romero, J. Dot, M. Abu-Suboh, M. Quintana, J.R. Armengol, J. Alvarez-Sabin (Barcelona, Spain)

1:45pm-3:15pm: Sleepiness and depression in Korean patients with Parkinson’s disease treated with ropinirole and levodopa

S.Y. Kang, H.-S. Ryu, M.-K. Sunwoo, S.-J. Kim, J.-S. Baik, M.-Y. Park, H.-E. Park, J.-S. Kim, K.-Y. Kwon, S.-B. Koh, Y.-E. Kim, M.-K. Lee, J.-M. Kim, S.J. Chung, Y.-H. Sohn (Hwaseong, Republic of Korea)

1:45pm-3:15pm: Speech and voice response to levodopa in late-stage Parkinson’s Disease patients: report from an acute levodopa challenge

M. Fabbri, I. Guimarães, M. Coelho, R. Cardoso, L. Guedes, M. Rosa, C. Godinho, A. Antonini, J. Ferreira (Lisbon, Portugal)

1:45pm-3:15pm: Speech Markers Estimate Motor Severity and Global Cognition in Parkinson’s Disease

K. Smith, T. Quatieri, J. Williamson (Worcester, MA, USA)

1:45pm-3:15pm: Subjective visual vertical in patients with early Parkinson’s disease

H.S. Kim, H. Lee, S. Chu (Kyunggi-do, Republic of Korea)

1:45pm-3:15pm: Subthalamic nucleus local field potential activity during the sleep-wake cycle

A. Tekriwal, J. Thompson, A. Abosch (Aurora, CO, USA)

1:45pm-3:15pm: The complex relationship between olfactory and cognitive impairment in Parkinson’s disease

J. Djordjevic, N.S. Saadat, A. Sadikot, T. White (Montreal, QC, Canada)

1:45pm-3:15pm: The effect and mechanism of acupuncture for pain in Parkinson’s disease

S.-W. Yu, Y.-R. Wu, J.-J. Wang, C.-C. Tsai (Taoyuan, Taiwan)

1:45pm-3:15pm: The impact of divided attention in dual task conditions on drooling in Parkinson’s Disease (PD): a pilot study

H. Reynolds, N. Miller, R. Walker (Gateshead, United Kingdom)

1:45pm-3:15pm: The impact of intensive voice treatment on swallowing in Parkinson disease

D. McFarland, L. Ramig, B. Martin-Harris, K. Humphries, J. Logemann, K. Freeman, A. Halpern, J. Spielman (Montréal, QC, Canada)

1:45pm-3:15pm: The impact of Parkinson’s disease on faith and spirituality

A. Weldehana (Addis Ababa, Ethiopia)

1:45pm-3:15pm: The influence of sleep disordered breathing in REM sleep behavior disorder associated symptoms

P. Bugalho, M. Mendonça, M. Salavisa, R. Barbosa (Lisbon, Portugal)

1:45pm-3:15pm: The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden

P. Hagell, M. Nilsson, R. Chaudhuri, P. Odin (Kristianstad, Sweden)

1:45pm-3:15pm: The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease

D.-Y. Kwon (Ansan, Republic of Korea)

1:45pm-3:15pm: The Superior Colliculus is impaired in de novo Parkinson’s disease patients

E. BELLOT, E. BELLOT, V. COIZET, S. MEONI, P. PELISSIER, B. DEBU, M. DOJAT, E. MORO (LA TRONCHE, France)

1:45pm-3:15pm: Translation and validation of the Filipino version of the wearing-off questionnaire-19 (F-WOQ-19)

K. Remigio, R.D. Jamora (Manila, Philippines)

1:45pm-3:15pm: Two-year prospective study reveals that gut dysbiosis predicts progression of Parkinson’s disease

M. Hirayama, T. Minato, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, T. Maeda, K. Ohno (Nagoya, Japan)

1:45pm-3:15pm: Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment

D. Weintraub, J. Norton, D. Fredericks, B. Coate, C. Andersson, C. Ballard (Philadelphia, PA, USA)

1:45pm-3:15pm: Validation of the performance based Erlangen Test of Activities of Daily Living in PD

I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg (Tübingen, Germany)

1:45pm-3:15pm: Validation of the Utility of Brief Smell Identification Test Simplified Chinese Version 2 in Chinese Parkinson’s disease

M. Cao (Beijing, China)

1:45pm-3:15pm: Videoendoscopy study of swallowing in Parkinson’s disease

J. Fukae, Y. Tsuboi, S. Fujioka, G. Umemoto (Fukuoka, Japan)

1:45pm-3:15pm: Vmat2 heterozygote mice display motor dysfunction and progressive depressive-like behaviors

K. Ma, J. Huang, L. Liu, C. Han, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

1:45pm-3:15pm: Weight loss in Parkinson’s disease (PD)

K. Khalid, D. Linsky, H. Khan, S. Pradhan, A. Chatterjee (Reading, United Kingdom)

1:45pm-3:15pm: What impacts relationship satisfaction in Parkinsonian dementias?

S. Vatter, K. McDonald, S. McCormick, I. Leroi (Manchester, United Kingdom)

1:45pm-3:15pm: Where Are The Main Lesions That Cause Orthostatic Hypotension In Parkinson’s Disease ?

R. Sengoku, M. Shibukawa, M. Yamazaki, K. Eguchi, M. Higashihara, D. Kaneda, Y. Nishina, K. Kanemaru, S. Murayama (Tokyo, Japan)

« View all sessions from the 21st International Congress.